What exactly happened is still open to debate but I can see why the funds originally earmarked for Medcann fit-out has been proposed for BioHealth project.
BioHealth are not going to front the costs of inventory or expansion into Asian/Aus markets.
We do need the funds for BioHealth deal..Just a question of if we could have held onto Medcann acquisition & at what cost to CGB.
Cheers .